FDA Inspection 1162459 — AHN Center for Reproductive Medicine

AHN Center for Reproductive Medicine — FEI 3004571445

The FDA completed an inspection of AHN Center for Reproductive Medicine on February 9, 2022 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 9, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Pittsburgh, PA (United States)